Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You and Your Team.

Learn More →

Association of Early Palliative Care With Survival in Patients With Advanced Lung Cancer—Reply

Association of Early Palliative Care With Survival in Patients With Advanced Lung Cancer—Reply Letters male patients with breast cancer. The authors presented both more likely to present in patients diagnosed with earlier stages 3 1 mortality analyses and survival analyses. Overall survival was of breast cancer. However, in our study, the mortality dis- the primary outcome and was defined as months from cancer parity between male and female patients with breast cancer diagnosis to death of any cause. The difference in survival be- existed across all cancer stages. In fact, the mortality differ- tween men and women was reported for 3-year, 5-year, and ence between men and women with stage I breast cancer was overall survival and stratified by disease stage. slightly smaller than the difference between men and women During the study period (January 2004 through Decem- with stage II and III cancers. These results suggest that lead- ber 2014), the incidence of breast cancer in women 40 years time bias is not the sole explanation for the disparity that we and older in the United States was greater than 200 in 100 000 observed between men and women. women. During the same period, more than 60% of women 40 years and older underwent breast cancer screening. Hence, Fei Wang, MD, http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png JAMA Oncology American Medical Association

Association of Early Palliative Care With Survival in Patients With Advanced Lung Cancer—Reply

JAMA Oncology , Volume 6 (3) – Mar 16, 2020

Loading next page...
 
/lp/american-medical-association/association-of-early-palliative-care-with-survival-in-patients-with-Onk0dKS6L0
Publisher
American Medical Association
Copyright
Copyright 2020 American Medical Association. All Rights Reserved.
ISSN
2374-2437
eISSN
2374-2445
DOI
10.1001/jamaoncol.2019.6301
Publisher site
See Article on Publisher Site

Abstract

Letters male patients with breast cancer. The authors presented both more likely to present in patients diagnosed with earlier stages 3 1 mortality analyses and survival analyses. Overall survival was of breast cancer. However, in our study, the mortality dis- the primary outcome and was defined as months from cancer parity between male and female patients with breast cancer diagnosis to death of any cause. The difference in survival be- existed across all cancer stages. In fact, the mortality differ- tween men and women was reported for 3-year, 5-year, and ence between men and women with stage I breast cancer was overall survival and stratified by disease stage. slightly smaller than the difference between men and women During the study period (January 2004 through Decem- with stage II and III cancers. These results suggest that lead- ber 2014), the incidence of breast cancer in women 40 years time bias is not the sole explanation for the disparity that we and older in the United States was greater than 200 in 100 000 observed between men and women. women. During the same period, more than 60% of women 40 years and older underwent breast cancer screening. Hence, Fei Wang, MD,

Journal

JAMA OncologyAmerican Medical Association

Published: Mar 16, 2020

References